期刊文献+

散发性乳腺癌中MTA1表达与ERα甲基化关系的研究 被引量:2

Relation between estrogen receptor-alpha promoter methylation and MTA1 expression in sporadic breast cancer
下载PDF
导出
摘要 目的:通过甲基化特异性PCR和免疫组化研究女性散发性乳腺癌中ERα基因启动子区甲基化和MTA1蛋白表达的相关性。方法:甲基化PCR研究102例散发性乳腺癌ERα启动子甲基化情况,免疫组化研究其MTA1蛋白表达情况。结果:乳腺癌组织中ERα启动子甲基化率为37.3%,乳腺癌组织中MTA1表达率为29.4%,高于其在癌旁正常乳腺组织中的表达(P<0.05),MTA1表达和ERα启动子甲基化均与乳腺肿瘤大小、TNM分期及淋巴结转移相关(P<0.05),且乳腺癌中ERα启动子甲基化与MTA1阳性表达呈正相关(P<0.05)。结论:女性散发性乳腺癌中ERα基因启动子甲基化与MTA1表达升高密切相关,其在乳腺癌发展过程中可能起重要作用。 Objective:To study the relation between the promoter methylation of estrogen receptor-alpha and MTA1 expression in sporadic breast cancer by methylation-specific polymerase chain reaction and immunohistochemistry.Methods:The methylation of ERα promoter was investigated by methylation-specific polymerase chain reaction and MTA1 expression was analyzed by immunohistochemistry in 102 sporadic breast cancer.Results: ERα methylation was observed in 37.3% breast cancer tissues and MTA1 expression in breast cancer(30/102,29.4%) was higher than that in non-neoplastic breast tissues(6/102,5.9%)(P0.05).Both of them were significantly associated with lymph node metastasis and tumor size and TNM stage in breast cancer(P0.05).ERα methylation had significant correlation with the MTA1 expression(P0.05).Conclusion:The ERα methylation status had tight relation with MTA1 expression in female sporadic breast cancer,and they may play important roles in the carcinogenesis of breast cancer.
出处 《现代肿瘤医学》 CAS 2013年第6期1228-1231,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:No.30950009) 辽宁省博士科研启动基金项目(编号:No.20121126)
关键词 乳腺癌 MTA1 ERα甲基化 breast cancer MTA1 ERα methylation
  • 相关文献

参考文献12

  • 1Zhang Y, Bu Y,Gao H. Rural - urban disparities of breast cancerpatients in China [J]. Med Oncol,2013 ,30( 1 ) :387.
  • 2Willems P,De Ruyck K, Van den Broecke R,et al. A polymorphismin the promoter region of Ku70/XRCC6,associated with breastcancer risk and oestrogen exposure [ J] . J Cancer Res Clin Oncol,2009,135(9):1159 -1168.
  • 3Dunnwald LK,Rossing MA,Li Cl. Hormone receptor status,tumorcharacteristics,and prognosis: a prospective cohort of breast cancerpatients [ J] . Breast Cancer Res,2007 ,9(1) :R6.
  • 4Murakami M,Kaul R,Robertson ES. MTA1 expression is linked toovarian cancer [ ]] . Cancer Biol Ther,2008 ,7(9) :1468 - 1470.
  • 5Ghanta KS,Li DQ,Eswaran J,et al. Gene profiling of MTA1 identi-fies novel gene targets and functions [ J]. PLoS One,2011,6(2):el7135.
  • 6Kurebayashi J. Current clinical trials of endocrine therapy for breastcancer [ J]. Breast Cancer,2007,14(2) :200 -214.
  • 7Lapidus RG,Nass SJ,Butash KA,et al. Mapping of ER gene CpGisland methylation — specific polymerase chain reaction [ J]. CancerRes,1998,58(12) :2515 -2519.
  • 8Zhao L, Wang L, Jin F,et al. Silencing of estrogen receptor alpha(ERalpha) gene by promoter hypermethylation is a frequent eventin Chinese women with sporadic breast cancer [ J] . Breast CancerRes Treat,2009,117(2) :253 -259.
  • 9Ghanta .KS,Li DQ,Eswaran J,et al. Gene profiling of MTA1 identi-fies novel gene targets and functions [ J] . PLoS One,2011,6(2):el7135.
  • 10Jang KS,Paik SS,Chung H,et al. MTA1 overexpression correlatessignificantly with tumor grade and angiogenesis in human breastcancers [ J]. Cancer Sci,2006,97(5) :374 -379.

同被引文献32

  • 1Wei J, Han B, Mao XY, et al. Promoter methylation status and exoression of estrogen receotor aloha in familial breast cancerpatients[J]. Turnout Biol, 2012, 33(2): 413-420.
  • 2Zhao L, Wang L, Jin F, et al. Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypennethylation is a frequent event in Chinese women with sporadic breast cancer[J]. Breast Cancer Res Treat, 2009, 117(2): 253-259.
  • 3Wei M, Xu J, Dignam J, et al. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers[J]. Breast Cancer Res Treat, 2008, 111(1): 113-120.
  • 4Thewes V, Simon R, Schroeter P, et al. Reprogramming of the ERR c and ERa target gene landscapetriggers tamoxifen resistance in breast cancer[J]. Cancer Res, 2015, 75(4): 720-731.
  • 5Zhang X, Park H, Han SS, et aI. ERc regulates chromosome alignment and spindle dynamics during mitosis[J]. Biochem Biophys Res Commun, 2015, 456(4): 919-925.
  • 6Chai F, Liang Y, Bi J, et al. REG "/ regulates ER cL degradation via ubiquitin-proteasome pathway in breast cancer[J]. Bioehem Biophys Res Commun, 2015, 456(1): 534-540.
  • 7Irluang B, Warner M, Gustafsson JA. Estrogen receptors in breast carcinogenesis and endocrine therapy[J]. Mol Cell Endocrinol, 2014, 26, doi: 10,1016/j.mce,2014,11.015. [Epub ahead of print].
  • 8Xue H, Wang H, Liu J, et al. MTA1 downregulation inhibitsmalignant potential in a small cell lung cancer cell line[J]. Oncol Rep, 2015, 33(2): 885-892.
  • 9Yang QY, Li JH, Wang QY, et al. MTA1 promotes cell proliferation via DNA damage repair in epithelial ovarian cancer[J]. Genet Mol Res, 2014, 13(4): 10269-10278.
  • 10Yuan T, Zhang H, Liu B, et al. Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis[J]. Med Oncol, 2014, 31(12): 330.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部